Scinai Immunotherapeutics (NASDAQ:SCNI) Issues Quarterly Earnings Results, Beats Expectations By $8.80 EPS

Scinai Immunotherapeutics (NASDAQ:SCNI) posted its quarterly earnings data on Monday. The company reported $0.30 EPS for the quarter, beating the consensus estimate of ($8.50) by $8.80, FiscalAI reports. The company had revenue of $1.86 million during the quarter, compared to the consensus estimate of $0.49 million.

Scinai Immunotherapeutics Stock Performance

NASDAQ SCNI opened at $0.44 on Monday. The stock has a market capitalization of $595,350.00, a price-to-earnings ratio of -0.00 and a beta of 2.27. The stock’s 50 day moving average price is $1.28 and its two-hundred day moving average price is $4.27. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.35 and a current ratio of 1.56. Scinai Immunotherapeutics has a 52 week low of $0.39 and a 52 week high of $13.00.

Scinai Immunotherapeutics shares are set to reverse split before the market opens on Thursday, November 19th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, November 18th.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Scinai Immunotherapeutics from a “sell (e)” rating to a “sell (e+)” rating in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) is an Israel-based clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for autoimmune and inflammatory diseases. The company’s research is centered on treatments intended to modulate disease-related immune responses while potentially limiting systemic exposure and associated side effects.

Scinai’s technology platform is based on NanoAb antibody fragments, which are designed to bind specific biological targets and may be suitable for local administration.